Low-Energy Selective Laser Trabeculoplasty Repeated Annually: Rationale for the COAST Trial.

Abstract

3459. Association for Research in Vision and Ophthalmology Annual Meeting; May 1, 2018, 2018; Honolulu, HA. 2. The Glaucoma Laser Trial (GLT) and Glaucoma Laser Trial Follow-Up Study: 7. Results. Glaucoma Laser Trial Research Group. Am J Ophthalmol. 1995;120(6):718-731. 3. Richter GM, Coleman AL. Minimally invasive glaucoma surgery: current status and future prospects. Clinical Ophthalmology. 2016;10:189-206. 4. Agrawal P, Bradshaw SE. Systematic Literature Review of Clinical and Economic Outcomes of Micro-Invasive Glaucoma Surgery (MIGS) in Primary Open-Angle Glaucoma. Ophthalmol Ther. 2018;7(1):49-73. 5. Kerr NM, Wang J, Barton K. Minimally invasive glaucoma surgery as primary stand-alone surgery for glaucoma. Clin Exp Ophthalmol. 2017;45(4):393-400. 6. Bovee CE, Pasquale LR. Evolving Surgical Interventions in the Treatment of Glaucoma. Semin Ophthalmol. 2017;32(1):91-95. 7. Lavia C, Dallorto L, Maule M, Ceccarelli M, Fea AM. Minimally-invasive glaucoma surgeries (MIGS) for open angle glaucoma: A systematic review and meta-analysis. PLoS One. 2017;12(8):e0183142. 8. Hutnik C, Crichton A, Ford B, et al. Selective Laser Trabeculoplasty versus Argon Laser Trabeculoplasty in Glaucoma Patients Treated Previously with 360 degrees Selective Laser Trabeculoplasty: A Randomized, Single-Blind, Equivalence Clinical Trial. Ophthalmology. 2019;126(2):223-232. 9. Francis BA, Loewen N, Hong B, et al. Repeatability of selective laser trabeculoplasty for openangle glaucoma. BMC Ophthalmol. 2016;16:128. 10. Durr GM, Harasymowycz P. The effect of repeat 360-degree selective laser trabeculoplasty on intraocular pressure control in open-angle glaucoma. J Fr Ophtalmol. 2016;39(3):261-264. 11. Polat J, Grantham L, Mitchell K, Realini T. Repeatability of selective laser trabeculoplasty. Br J Ophthalmol. 2016;100(10):1437-1441. 12. Khouri AS, Lari HB, Berezina TL, Maltzman B, Fechtner RD. Long term efficacy of repeat selective laser trabeculoplasty. J Ophthalmic Vis Res. 2014;9(4):444-448. 13. Khouri AS, Lin J, Berezina TL, Maltzman B, Fechtner RD. Repeat selective laser trabeculoplasty can be effective in eyes with initial modest response. Middle East Afr J Ophthalmol. 2014;21(3):205-209. 14. Avery N, Ang GS, Nicholas S, Wells A. Repeatability of primary selective laser trabeculoplasty in patients with primary open-angle glaucoma. Int Ophthalmol. 2013;33(5):501-506. 15. Hong BK, Winer JC, Martone JF, Wand M, Altman B, Shields B. Repeat selective laser trabeculoplasty. J Glaucoma. 2009;18(3):180-183. 16. Gazzard G, Konstantakopoulou E, Garway-Heath D, et al. Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial. Lancet. 2019;393(10180):1505-1516. 17. Newman-Casey PA, Dayno M, Robin AL. Systematic Review of Educational Interventions to Improve Glaucoma Medication Adherence: an update in 2015. Expert Rev Ophthalmol. 2016;11(1):5-20. 18. Newman-Casey PA, Weizer JS, Heisler M, Lee PP, Stein JD. Systematic review of educational interventions to improve glaucoma medication adherence. Semin Ophthalmol. 2013;28(3):191201. 19. Friedman DS, Quigley HA, Gelb L, et al. Using pharmacy claims data to study adherence to glaucoma medications: methodology and findings of the Glaucoma Adherence and Persistency Study (GAPS). Invest Ophthalmol Vis Sci. 2007;48(11):5052-5057. Copyright © 2021 Wolters Kluwer Health, Inc. Unauthorized reproduction of the article is prohibited. AC CE PT ED 20. Tsai JC. A comprehensive perspective on patient adherence to topical glaucoma therapy. Ophthalmology. 2009;116(11 Suppl):S30-36. 21. Tsai JC. Medication adherence in glaucoma: approaches for optimizing patient compliance. Curr Opin Ophthalmol. 2006;17(2):190-195. 22. Tsai JC, McClure CA, Ramos SE, Schlundt DG, Pichert JW. Compliance barriers in glaucoma: a systematic classification. J Glaucoma. 2003;12(5):393-398. 23. Muir KW, Lee PP. Glaucoma medication adherence: room for improvement in both performance and measurement. Arch Ophthal. 2011;129(2):243-245. 24. Kass MA, Gordon MO, Gao F, et al. Delaying treatment of ocular hypertension: the ocular hypertension treatment study. Arch Ophthalmol. 2010;128(3):276-287. 25. Katz LJ, Steinmann WC, Kabir A, et al. Selective laser trabeculoplasty versus medical therapy as initial treatment of glaucoma: a prospective, randomized trial. J Glaucoma. 2012;21(7):460-468. 26. Arora V, Bali SJ, Gupta SK, et al. Impact of initial topical medical therapy on short-term quality of life in newly diagnosed patients with primary glaucoma. Indian J Ophthalmol. 2015;63(6):511515. 27. Balkrishnan R, Bond JB, Byerly WG, Camacho FT, Anderson RT. Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a medicare health maintenance organization. Am J Geriatr Pharmacother. 2003;1(2):75-81. 28. Gupta V, Dutta P, Ov M, Kapoor KS, Sihota R, Kumar G. Effect of glaucoma on the quality of life of young patients. Invest Ophthalmol Vis Sci. 2011;52(11):8433-8437. 29. Basilio AL, Moura-Coelho N, Passos I, et al. XEN((R)) implant and trabeculectomy mediumterm quality of life assessment and comparison of results. Int J Ophthalmol. 2018;11(12):19411944. 30. American Academy of Ophthalmology. Primary open-angle glaucoma: Preferred Practice Pattern. San Francisco: American Academy of Ophthalmology; 2015. 31. European Glaucoma Society. Terminology and Guidelines for Glaucoma. 4th Edition. In. Savona, Italy: PubliComm; 2014. 32. Fechtner RD, Godfrey DG, Budenz D, Stewart JA, Stewart WC, Jasek MC. Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea. 2010;29(6):618-621. 33. Leung EW, Medeiros FA, Weinreb RN. Prevalence of ocular surface disease in glaucoma patients. J Glaucoma. 2008;17(5):350-355. 34. Baudouin C, Labbe A, Liang H, Pauly A, Brignole-Baudouin F. Preservatives in eyedrops: The good, the bad and the ugly. Prog Retin Eye Res. 2010. 35. Wittenborn JS, Rein DB. Cost-effectiveness of glaucoma interventions in Barbados and Ghana. Optom Vis Sci. 2011;88(1):155-163. 36. Stein JD, Kim DD, Peck WW, Giannetti SM, Hutton DW. Cost-effectiveness of medications compared with laser trabeculoplasty in patients with newly diagnosed open-angle glaucoma. Arch Ophthalmol. 2012;130(4):497-505. 37. McIlraith I, Strasfeld M, Colev G, Hutnik CM. Selective laser trabeculoplasty as initial and adjunctive treatment for open-angle glaucoma. J Glaucoma. 2006;15(2):124-130. 38. Nagar M, Ogunyomade A, O Brart DP, Howes F, Marshall J. A randomised, prospective study comparing selective laser trabeculoplasty with latanoprost for the control of intraocular pressure in ocular hypertension and open angle glaucoma. Br J Ophthalmol. 2005;89(11):1413-1417. 39. Realini T, Shillingford-Ricketts H, Burt D, Balasubramani GK. West Indies Glaucoma Laser Study (WIGLS): 1. 12-Month Efficacy of Selective Laser Trabeculoplasty in Afro-Caribbeans With Glaucoma. Am J Ophthalmol. 2017;184:28-33. 40. Realini T. Selective laser trabeculoplasty for the management of open-angle glaucoma in St. Lucia. JAMA Ophthalmol. 2013;131(3):321-327. 41. Ouattara OAS, Coulibaly F, Ouffoue YG, et al. [Selective laser trabeculoplasty in African blacks]. J Fr Ophtalmol. 2019;42(1):44-48. Copyright © 2021 Wolters Kluwer Health, Inc. Unauthorized reproduction of the article is prohibited. AC CE PT ED 42. Goosen E, Coleman K, Visser L, Sponsel WE. Racial Differences in Selective Laser Trabeculoplasty Efficacy. J Curr Glaucoma Pract. 2017;11(1):22-27. 43. Seck SM, Agboton G, Dieng M, et al. [Selective laser trabeculoplasty (SLT): our experience in African blacks]. J Fr Ophtalmol. 2015;38(3):238-246. 44. Tham YC, Li X, Wong TY, Quigley HA, Aung T, Cheng CY. Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis. Ophthalmology. 2014;121(11):2081-2090. 45. Bourne RR, Taylor HR, Flaxman SR, et al. Number of People Blind or Visually Impaired by Glaucoma Worldwide and in World Regions 1990 2010: A Meta-Analysis. PLoS ONE. 2016;11(10):e0162229. 46. Realini T. Five Years’ Experience with Selective Laser Trabeculoplasty in St. Lucia. European Glaucoma Society Annual Meeting; June 2016, 2016; Prague, Czech Republic. 47. Realini T. Selective laser trabeculoplasty: a review. J Glaucoma. 2008;17(6):497-502. 48. Song J. Complications of selective laser trabeculoplasty: a review. Clin Ophthalmol. 2016;10:137-143. 49. Damji KF, Shah KC, Rock WJ, Bains HS, Hodge WG. Selective laser trabeculoplasty v argon laser trabeculoplasty: a prospective randomised clinical trial. Br J Ophthalmol. 1999;83(6):718722. 50. Popiela G, Muzyka M, Szelepin L, Cwirko M, Nizankowska MH. [Use of YAG-Selecta laser and argon laser in the treatment of open angle glaucoma]. Klin Oczna. 2000;102(2):129-133. 51. Martinez-de-la-Casa JM, Garcia-Feijoo J, Castillo A, et al. Selective vs argon laser trabeculoplasty: hypotensive efficacy, anterior chamber inflammation, and postoperative pain. Eye. 2004;18(5):498-502. 52. Damji KF, Bovell AM, Hodge WG, et al. Selective laser trabeculoplasty versus argon laser trabeculoplasty: results from a 1-year randomised clinical trial. Br J Ophthalmol. 2006;90(12):1490-1494. 53. Best UP, Domack H, Schmidt V. [Pressure reduction after selective laser trabeculoplasty with two different laser systems and after argon laser trabeculoplasty a controlled prospective clinical trial on 284 eyes.]. Klin Monatsbl Augenheilkd. 2007;224(3):173-179. 54. Juzych MS, Chopra V, Banitt MR, et al. Comparison of long-term outcomes of selective laser trabeculoplasty versus argon laser trabeculoplasty in open-angle glaucoma. Ophthalmology. 2004;111(10):1853-1859. 55. Van de Veire S, Zeyen T, Stalmans I. Argon versus selective laser trabeculoplasty. Bull Soc Belge Ophtalmol. 2006(299):5-10. 56. Garg A, Vickerstaff V, Nathwani N, et al. Primary Selective Laser Trabeculoplasty for O